Molnupiravir for COVID-19 – Is it a Magic Pill or just a Hype in the Making?
Merck’s Molnupiravir, an oral antiviral treatment is set for review by the FDA Advisory Panel. If approved, Molnupiravir will be the first oral antiviral treatment authorized for the treatment of COVID-19. This experimental drug was developed by Merck and Ridgeback Biotherapeutics. This comes at the back drop of several drugs failing to prove their efficacy,…